Determination of urinary 8-epi-prostaglandin F2α using liquid chromatography-tandem mass spectrometry: increased excretion in diabetics
- 3 July 2000
- journal article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 62 (2) , 173-181
- https://doi.org/10.1016/s0090-6980(00)00061-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid Peroxidation—A Comparison of Enzyme Immunoassay with Gas Chromatography/Mass SpectrometryAnalytical Biochemistry, 1999
- Increased urinary F2-isoprostane excretion in alcoholic liver diseaseFree Radical Biology & Medicine, 1999
- An Improved Method for the Measurement of Urinary and Plasma F2-Isoprostanes Using Gas Chromatography–Mass SpectrometryAnalytical Biochemistry, 1999
- Increased F2‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidationin vivoThe FASEB Journal, 1998
- Exhaled Breath Condensate Isoprostanes Are Elevated in Patients With Acute Lung Injury or ARDSChest, 1998
- Advances in instrumentation in liquid chromatography–mass spectrometry and related liquid-introduction techniquesJournal of Chromatography A, 1998
- The Isoprostanes: A PerspectiveProstaglandins, 1997
- Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The generation and actions of isoprostanesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1997
- Measurement of urinary 8-epi-prostaglandin f2α, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokersFree Radical Biology & Medicine, 1996